搜索临床试验以:SY-5007 tablets
总计4147个结果
-
Shouyao Holdings (Beijing) Co. LTD招聘中
-
Shouyao Holdings (Beijing) Co. LTD招聘中
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.完全的
-
Instituto de Investigación Hospital Universitario...Go Fruselva, S.L.完全的
-
Shouyao Holdings (Beijing) Co. LTD招聘中
-
ANRS, Emerging Infectious DiseasesUniversity College London Hospitals; Hospital Clinic of Barcelona; Imperial College London; Erasmus... 和其他合作者完全的
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中弥漫性大 B 细胞淋巴瘤 | 复发性套细胞淋巴瘤 | 套细胞淋巴瘤 | B细胞非霍奇金淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 复发性转化非霍奇金淋巴瘤 | 转化的非霍奇金淋巴瘤美国
-
University of Maryland, BaltimoreArbutus Biopharma Corporation尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.招聘中复发性 B 型急性淋巴细胞白血病 | 难治性 B 型急性淋巴细胞白血病 | 费城染色体阳性 | 破坏 5% 或更多的骨髓有核细胞 | CD22阳性美国
-
M.D. Anderson Cancer Center主动,不招人胰腺导管腺癌 | IV 期胰腺癌 AJCC v8 | 转移性胰腺癌 | KRAS NP_004976.2:p.G12D美国
-
Takeda主动,不招人
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR); Queen's University终止
-
Biofourmis Singapore Pte Ltd.Mayo Clinic; Food and Drug Administration (FDA)终止
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.完全的
-
University of Santo Tomas Hospital, PhilippinesPhilippine Council for Health Research & Development尚未招聘局部晚期宫颈癌
-
Andrei IagaruNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的